Morgan Stanley Maintains a Hold on Centene Corporation (CNC)

The standing update came the aforesaid time Centene Corporation (NYSE:CNC) announced its 2025 results and guidance, reporting 2025 afloat twelvemonth GAAP diluted nonaccomplishment per stock of $13.53 and adjusted diluted Earnings Per Share of $2.08. Management reported a consolidated HBR of 94.3% successful fiscal Q4 2025, which includes a Commercial HBR of 95.4%, which was 100 ground points supra expectations, driven by nett out-of-period items. In addition, Medicaid HBR was 93.0% successful the quarter, representing 40 ground points of sequential betterment compared to Q3 and reflecting continued progress.

Centene Corporation (NYSE:CNC) further stated that it is positioned to present renewed adjusted diluted EPS maturation and meaningful borderline betterment successful 2026, and expects full-year 2026 adjusted diluted EPS to beryllium greater than $3.00. This marks important advancement toward restoring the enterprise’s embedded net power.

Centene Corporation (NYSE:CNC) is simply a healthcare endeavor that provides programs and services to government-sponsored healthcare programs. The company’s operations are divided into the pursuing segments: Medicaid, Medicare, Commercial, and Other.

While we admit the imaginable of CNC arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.